Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The global Insulin Drug and Delivery Technologies market is projected to grow from US$ 36000 million in 2023 to US$ 61720 million by 2029, at a Compound Annual Growth Rate (CAGR) of 9.4% during the forecast period.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.
Report Includes:
This report presents an overview of global market for Insulin Drug and Delivery Technologies, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Insulin Drug and Delivery Technologies, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Insulin Drug and Delivery Technologies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Insulin Drug and Delivery Technologies sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Insulin Drug and Delivery Technologies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Insulin Drug and Delivery Technologies sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Eli Lilly and Company, Biocon, Julphar, Ypsomed and Becton, Dickinson and Company, etc.
By Company
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Segment by Type
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Segment by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Insulin Drug and Delivery Technologies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Insulin Drug and Delivery Technologies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Drug and Delivery Technologies sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Insulin Drug and Delivery Technologies Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Insulin Syringes
1.2.3 Insulin Vials
1.2.4 Insulin Pens
1.2.5 Insulin Pumps
1.3 Market by Application
1.3.1 Global Insulin Drug and Delivery Technologies Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diabetes Mellitus Type 1
1.3.3 Diabetes Mellitus Type 2
1.3.4 Gestational Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Insulin Drug and Delivery Technologies Sales Estimates and Forecasts 2018-2029
2.2 Global Insulin Drug and Delivery Technologies Revenue by Region
2.2.1 Global Insulin Drug and Delivery Technologies Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Insulin Drug and Delivery Technologies Revenue by Region (2018-2023)
2.2.3 Global Insulin Drug and Delivery Technologies Revenue by Region (2024-2029)
2.2.4 Global Insulin Drug and Delivery Technologies Revenue Market Share by Region (2018-2029)
2.3 Global Insulin Drug and Delivery Technologies Sales Estimates and Forecasts 2018-2029
2.4 Global Insulin Drug and Delivery Technologies Sales by Region
2.4.1 Global Insulin Drug and Delivery Technologies Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Insulin Drug and Delivery Technologies Sales by Region (2018-2023)
2.4.3 Global Insulin Drug and Delivery Technologies Sales by Region (2024-2029)
2.4.4 Global Insulin Drug and Delivery Technologies Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Insulin Drug and Delivery Technologies Sales by Manufacturers
3.1.1 Global Insulin Drug and Delivery Technologies Sales by Manufacturers (2018-2023)
3.1.2 Global Insulin Drug and Delivery Technologies Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Drug and Delivery Technologies in 2022
3.2 Global Insulin Drug and Delivery Technologies Revenue by Manufacturers
3.2.1 Global Insulin Drug and Delivery Technologies Revenue by Manufacturers (2018-2023)
3.2.2 Global Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Drug and Delivery Technologies Revenue in 2022
3.3 Global Key Players of Insulin Drug and Delivery Technologies, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Insulin Drug and Delivery Technologies Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Insulin Drug and Delivery Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Insulin Drug and Delivery Technologies, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Insulin Drug and Delivery Technologies, Product Offered and Application
3.8 Global Key Manufacturers of Insulin Drug and Delivery Technologies, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Drug and Delivery Technologies Sales by Type
4.1.1 Global Insulin Drug and Delivery Technologies Historical Sales by Type (2018-2023)
4.1.2 Global Insulin Drug and Delivery Technologies Forecasted Sales by Type (2024-2029)
4.1.3 Global Insulin Drug and Delivery Technologies Sales Market Share by Type (2018-2029)
4.2 Global Insulin Drug and Delivery Technologies Revenue by Type
4.2.1 Global Insulin Drug and Delivery Technologies Historical Revenue by Type (2018-2023)
4.2.2 Global Insulin Drug and Delivery Technologies Forecasted Revenue by Type (2024-2029)
4.2.3 Global Insulin Drug and Delivery Technologies Revenue Market Share by Type (2018-2029)
4.3 Global Insulin Drug and Delivery Technologies Price by Type
4.3.1 Global Insulin Drug and Delivery Technologies Price by Type (2018-2023)
4.3.2 Global Insulin Drug and Delivery Technologies Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Insulin Drug and Delivery Technologies Sales by Application
5.1.1 Global Insulin Drug and Delivery Technologies Historical Sales by Application (2018-2023)
5.1.2 Global Insulin Drug and Delivery Technologies Forecasted Sales by Application (2024-2029)
5.1.3 Global Insulin Drug and Delivery Technologies Sales Market Share by Application (2018-2029)
5.2 Global Insulin Drug and Delivery Technologies Revenue by Application
5.2.1 Global Insulin Drug and Delivery Technologies Historical Revenue by Application (2018-2023)
5.2.2 Global Insulin Drug and Delivery Technologies Forecasted Revenue by Application (2024-2029)
5.2.3 Global Insulin Drug and Delivery Technologies Revenue Market Share by Application (2018-2029)
5.3 Global Insulin Drug and Delivery Technologies Price by Application
5.3.1 Global Insulin Drug and Delivery Technologies Price by Application (2018-2023)
5.3.2 Global Insulin Drug and Delivery Technologies Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Insulin Drug and Delivery Technologies Market Size by Type
6.1.1 US & Canada Insulin Drug and Delivery Technologies Sales by Type (2018-2029)
6.1.2 US & Canada Insulin Drug and Delivery Technologies Revenue by Type (2018-2029)
6.2 US & Canada Insulin Drug and Delivery Technologies Market Size by Application
6.2.1 US & Canada Insulin Drug and Delivery Technologies Sales by Application (2018-2029)
6.2.2 US & Canada Insulin Drug and Delivery Technologies Revenue by Application (2018-2029)
6.3 US & Canada Insulin Drug and Delivery Technologies Market Size by Country
6.3.1 US & Canada Insulin Drug and Delivery Technologies Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Insulin Drug and Delivery Technologies Sales by Country (2018-2029)
6.3.3 US & Canada Insulin Drug and Delivery Technologies Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Insulin Drug and Delivery Technologies Market Size by Type
7.1.1 Europe Insulin Drug and Delivery Technologies Sales by Type (2018-2029)
7.1.2 Europe Insulin Drug and Delivery Technologies Revenue by Type (2018-2029)
7.2 Europe Insulin Drug and Delivery Technologies Market Size by Application
7.2.1 Europe Insulin Drug and Delivery Technologies Sales by Application (2018-2029)
7.2.2 Europe Insulin Drug and Delivery Technologies Revenue by Application (2018-2029)
7.3 Europe Insulin Drug and Delivery Technologies Market Size by Country
7.3.1 Europe Insulin Drug and Delivery Technologies Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Insulin Drug and Delivery Technologies Sales by Country (2018-2029)
7.3.3 Europe Insulin Drug and Delivery Technologies Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Insulin Drug and Delivery Technologies Market Size
8.1.1 China Insulin Drug and Delivery Technologies Sales (2018-2029)
8.1.2 China Insulin Drug and Delivery Technologies Revenue (2018-2029)
8.2 China Insulin Drug and Delivery Technologies Market Size by Application
8.2.1 China Insulin Drug and Delivery Technologies Sales by Application (2018-2029)
8.2.2 China Insulin Drug and Delivery Technologies Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Insulin Drug and Delivery Technologies Market Size by Type
9.1.1 Asia Insulin Drug and Delivery Technologies Sales by Type (2018-2029)
9.1.2 Asia Insulin Drug and Delivery Technologies Revenue by Type (2018-2029)
9.2 Asia Insulin Drug and Delivery Technologies Market Size by Application
9.2.1 Asia Insulin Drug and Delivery Technologies Sales by Application (2018-2029)
9.2.2 Asia Insulin Drug and Delivery Technologies Revenue by Application (2018-2029)
9.3 Asia Insulin Drug and Delivery Technologies Sales by Region
9.3.1 Asia Insulin Drug and Delivery Technologies Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Insulin Drug and Delivery Technologies Revenue by Region (2018-2029)
9.3.3 Asia Insulin Drug and Delivery Technologies Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Market Size by Type
10.1.1 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Market Size by Application
10.2.1 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Sales by Country
10.3.1 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Insulin Drug and Delivery Technologies Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Insulin Drug and Delivery Technologies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Information
11.2.2 Eli Lilly and Company Overview
11.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Eli Lilly and Company Insulin Drug and Delivery Technologies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly and Company Recent Developments
11.3 Biocon
11.3.1 Biocon Company Information
11.3.2 Biocon Overview
11.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Biocon Insulin Drug and Delivery Technologies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biocon Recent Developments
11.4 Julphar
11.4.1 Julphar Company Information
11.4.2 Julphar Overview
11.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Julphar Insulin Drug and Delivery Technologies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Julphar Recent Developments
11.5 Ypsomed
11.5.1 Ypsomed Company Information
11.5.2 Ypsomed Overview
11.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Ypsomed Insulin Drug and Delivery Technologies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ypsomed Recent Developments
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Information
11.6.2 Becton, Dickinson and Company Overview
11.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Becton, Dickinson and Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Drug and Delivery Technologies Industry Chain Analysis
12.2 Insulin Drug and Delivery Technologies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Drug and Delivery Technologies Production Mode & Process
12.4 Insulin Drug and Delivery Technologies Sales and Marketing
12.4.1 Insulin Drug and Delivery Technologies Sales Channels
12.4.2 Insulin Drug and Delivery Technologies Distributors
12.5 Insulin Drug and Delivery Technologies Customers
13 Market Dynamics
13.1 Insulin Drug and Delivery Technologies Industry Trends
13.2 Insulin Drug and Delivery Technologies Market Drivers
13.3 Insulin Drug and Delivery Technologies Market Challenges
13.4 Insulin Drug and Delivery Technologies Market Restraints
14 Key Findings in The Global Insulin Drug and Delivery Technologies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
听
听
*If Applicable.